Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Molecular processes identified in anxiety and alcoholism comorbidity

March 25, 2008

Merck Serono launches Cyanokit for cyanide poisoning in Japan

March 20, 2008

Cortex receives German approval for two Ampakine CX-717 trials

March 10, 2008

Akela initiate phase I clinical trial of Edacs abuse deterrent opioid

March 10, 2008

PharmAthene reports results from initial pharmacokinetic studies of Protexia

March 10, 2008

Neurokinin 1 receptor potential target for the treatment of alcoholism

March 7, 2008

Evotec commences phase II smoking cessation trial with EVT-302

Feb. 29, 2008

Protectan CBLB-502 significantly decreases adverse effects of chemotherapy in mice

Feb. 20, 2008

Recent Solvay patent describes new compounds for substance abuse and dependence

Feb. 8, 2008

DOR BioPharma achieves 2-year stability milestone for its ricin toxin vaccine

Feb. 1, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...